✦ LIBER ✦

A Curative Resection Improves the Postoperative Survival Rate Even in Patients with Advanced Gallbladder Carcinoma

✍ Scribed by Masahiro Kai; Kazuo Chijiiwa; Jiro Ohuchida; Motoaki Nagano; Masahide Hiyoshi; Kazuhiro Kondo

Book ID: 107409962
Publisher: Springer-Verlag
Year: 2007
Tongue: English
Weight: 171 KB
Volume: 11
Category: Article
ISSN: 1091-255X
DOI: 10.1007/s11605-007-0181-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term survival of a patient with adv

Long-term survival of a patient with advanced adenosquamous carcinoma of the gallbladder after radical resection

✍ Fujita, Takeo ;Fukuda, Kazuma ;Ohmura, Yasushi ;Nishi, Hideyuki ;Mano, Masayuki 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 312 KB

Does radical resection improve the survi

Does radical resection improve the survival in patients with carcinoma of the gallbladder who are 75 years old and older?

✍ Hirohiko Onoyama; Tetsuo Ajiki; Moriatsu Takada; Tomoaki Urakawa; Yoichi Saitoh 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 452 KB

Postoperative interferon α treatment pos

Postoperative interferon α treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial

✍ Hui-Chuan Sun; Zhao-You Tang; Lu Wang; Lun-Xiu Qin; Zeng-Chen Ma; Qin-Hai Ye; Bo 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 243 KB

The impact of age on toxicity, response

The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, Stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel

✍ Thomas A. Hensing; Amy H. Peterman; Michael J. Schell; Ji-Hyun Lee; Mark A. Soci 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

## Abstract ## BACKGROUND The optimal treatment strategy for elderly patients with advanced nonsmall cell lung carcinoma has not been defined to date. The authors performed a retrospective analysis of a Phase III trial that treated patients who had Stage IIIB or IV nonsmall cell lung carcinoma wit